Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanjing Medical UniversityNo recent work listed

Yuqing Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9873-9449; OpenAlex author ID A5101518257. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Laparoscopic ultrasonography-guided cryoablation of locally advanced pancreatic cancer: a preliminary report. First author DOI 10.1007/s11604-021-01175-9↗
  2. Long Intergenic Nonprotein Coding RNA 173 Inhibits Tumor Growth and Promotes Apoptosis by Repressing Sphingosine Kinase 1 Protein Expression in Pancreatic Canc… Co-author DOI 10.1089/dna.2020.6103↗
  3. Comparative peptidome profiling reveals critical roles for peptides in the pathology of pancreatic cancer. Co-author DOI 10.1016/j.biocel.2020.105687↗
  4. Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663. Co-author DOI 10.2147/ott.s261570↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhuyin Qian · 4 shared papers, 2020–2022 · strength 0.57
  2. Bin Zhang · 2 shared papers, 2020 · strength 0.25
  3. Xingxing Li · 2 shared papers, 2020–2021 · strength 0.24
  4. Yingchun Wu · 1 shared paper, 2022 · strength 0.19
  5. Qian Li · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.